This document defines the study outline that applicants should follow when preparing the paediatric investigation plan for a new diphtheria-tetanus-acellular-pertussis-containing combination vaccine (e.g. pentavalent, hexavalent, heptavalent), for a priming schedule and booster dose before two years of age.